Scientific Explanations in Health Sciences: Causality, Trust, and Epistemic Adequacy

The Limits of Explainability: Why Trust in Medical AI Requires More Than Just Explanations

The preprint from arXiv (2606.31616v1) tackles a foundational tension in medical AI: the gap between opaque machine learning models and the clinical need for trustworthy, causally grounded decisions. While the paper’s abstract focuses on explainability as a partial remedy, the deeper issue it raises is whether current explanation methods are epistemically adequate—that is, whether they actually provide the kind of understanding clinicians need to trust and act on AI recommendations.

What the Research Actually Addresses

The work interrogates the relationship between causality, trust, and what constitutes a “scientific explanation” in health sciences. It moves beyond the typical technical discussion of feature importance or saliency maps to ask a more fundamental question: Can an explanation that does not reference causal mechanisms ever be sufficient for clinical decision-making? This is a critical distinction. A model might tell a doctor that a patient’s risk score increased because of a specific lab value, but without understanding why that lab value is causally relevant to the outcome, the explanation remains superficial.

Why This Matters for Clinical AI Deployment

The stakes are high. In healthcare, trust is not a luxury—it is a prerequisite for adoption. Current explainability tools (LIME, SHAP, Grad-CAM) often produce post-hoc rationalizations that correlate with model behavior but do not reflect true causal structures. This creates a dangerous illusion of understanding. A clinician who trusts a model based on a misleading explanation may make incorrect treatment decisions. The paper’s emphasis on “epistemic adequacy” challenges the AI community to hold explanations to a higher standard: they must not only be interpretable, but also correct in a scientific sense.

Implications for AI Practitioners

For developers building medical AI systems, this research signals a shift in priorities. First, it suggests that investing in causal inference methods—such as structural causal models or counterfactual reasoning—may be more valuable than refining post-hoc explainers. Second, it implies that validation of explanations should include human-grounded evaluation with domain experts (clinicians), not just computational metrics. Third, it warns against deploying models in high-stakes settings unless the explanation pipeline can withstand scientific scrutiny.

The paper also implicitly critiques the current regulatory landscape. If an AI system’s explanation is not causally adequate, can it truly be said to be “explainable” in a way that satisfies FDA or CE marking requirements? This question will likely become a focal point for future policy.

Key Takeaways

• Causal adequacy is the new frontier: Post-hoc explanations are insufficient for clinical trust; explanations must reference causal mechanisms to be epistemically valid.
• Trust requires more than transparency: A model can be transparent yet misleading if its explanations do not align with scientific understanding of disease processes.
• Practitioners must prioritize causal modeling: Investing in causal inference and counterfactual reasoning is likely more impactful than refining feature-attribution methods.
• Regulatory standards may need updating: Current explainability requirements may not adequately assess whether an explanation is scientifically sound, not just technically interpretable.